a multiplex kit for IDH1 and IDH2 mutations detection in tumor DNA

The ready-to-use IDIDH1-2 kit is a multiplexed and sensitive tool for the detection and quantification by digital PCR (dPCR) of mutations in the IDH1 (Isocitrate DeHydrogenase (NADP(+)) 1, cytosolic) and IDH2 (Isocitrate DeHydrogenase (NADP(+)) 2, mitochondrial) genes involved in the classification of brain tumors in adults.

Mutations in IDH1 gene, located at 2q34, and IDH2 gene, located at 15q26.1, allow to distinguish between the subtypes of “low-grade” gliomas and secondary glioblastomas.

Technical specifications

This optimized kit provides a multiplex solution allowing, for each sample, to simultaneously amplify, in one PCR reaction, several variants in the both region of IDH1 (R132X – R132H, R132C, R132S, R132G, R132L) and IDH2  (R172X – R172W, R172G, R172K, R172M) (Ref: IDIDH1-2(s)-25).

This kit can be used on circulating cell-free DNA (cfDNA) extracted from plasma samples or DNA extracted from FFPE tissues.

It is compatible with Crystal Digital PCR ™ system (Stilla). 

Reference and formatIDIDH1-2(s)-25 (25 preps)
(s) Stilla
MatrixCirculating DNA extracted from plasma
Genomic DNA extracted from FFPE
Application Digital PCR (dPCR)
Duration of the protocol2h (Naica-12 samples)
Storage temperature-20°C
Stability1 year

IDIDH1-2 Tumor DNA IDH1 / IDH2 mutation Detection Kit


Characteristics of IDIDH1-2 kit


Documentation on request to